These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 1314606)

  • 1. Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80).
    Fry M; Pudney M
    Biochem Pharmacol; 1992 Apr; 43(7):1545-53. PubMed ID: 1314606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action.
    Birth D; Kao WC; Hunte C
    Nat Commun; 2014 Jun; 5():4029. PubMed ID: 24893593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of atovaquone (566C80) on the maturation and viability of Plasmodium falciparum gametocytes in vitro.
    Fleck SL; Pudney M; Sinden RE
    Trans R Soc Trop Med Hyg; 1996; 90(3):309-12. PubMed ID: 8758088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial type II NADH dehydrogenase of Plasmodium falciparum (PfNDH2) is dispensable in the asexual blood stages.
    Ke H; Ganesan SM; Dass S; Morrisey JM; Pou S; Nilsen A; Riscoe MK; Mather MW; Vaidya AB
    PLoS One; 2019; 14(4):e0214023. PubMed ID: 30964863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into cytochrome bc1 complex binding mode of antimalarial 2-hydroxy-1,4-naphthoquinones through molecular modelling.
    Sodero AC; Abrahim-Vieira B; Torres PH; Pascutti PG; Garcia CR; Ferreira VF; Rocha DR; Ferreira SB; Silva FP
    Mem Inst Oswaldo Cruz; 2017 Apr; 112(4):299-308. PubMed ID: 28327793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtle changes in endochin-like quinolone structure alter the site of inhibition within the cytochrome bc1 complex of Plasmodium falciparum.
    Stickles AM; de Almeida MJ; Morrisey JM; Sheridan KA; Forquer IP; Nilsen A; Winter RW; Burrows JN; Fidock DA; Vaidya AB; Riscoe MK
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1977-82. PubMed ID: 25605352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of tetracyclic benzothiazepines as Plasmodium falciparum cytochrome bc1 inhibitors.
    Dong CK; Urgaonkar S; Cortese JF; Gamo FJ; Garcia-Bustos JF; Lafuente MJ; Patel V; Ross L; Coleman BI; Derbyshire ER; Clish CB; Serrano AE; Cromwell M; Barker RH; Dvorin JD; Duraisingh MT; Wirth DF; Clardy J; Mazitschek R
    Chem Biol; 2011 Dec; 18(12):1602-10. PubMed ID: 22195562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of 4(1H)-pyridones as a novel family of potent antimalarial inhibitors of the plasmodial cytochrome bc1.
    Bueno JM; Herreros E; Angulo-Barturen I; Ferrer S; Fiandor JM; Gamo FJ; Gargallo-Viola D; Derimanov G
    Future Med Chem; 2012 Dec; 4(18):2311-23. PubMed ID: 23234553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The causal prophylactic activity of the novel hydroxynaphthoquinone 566C80 against Plasmodium berghei infections in rats.
    Davies CS; Pudney M; Matthews PJ; Sinden RE
    Acta Leiden; 1989; 58(2):115-28. PubMed ID: 2489391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncovering the molecular mode of action of the antimalarial drug atovaquone using a bacterial system.
    Mather MW; Darrouzet E; Valkova-Valchanova M; Cooley JW; McIntosh MT; Daldal F; Vaidya AB
    J Biol Chem; 2005 Jul; 280(29):27458-65. PubMed ID: 15917236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct evidence for the atovaquone action on the Plasmodium cytochrome bc1 complex.
    Siregar JE; Kurisu G; Kobayashi T; Matsuzaki M; Sakamoto K; Mi-ichi F; Watanabe Y; Hirai M; Matsuoka H; Syafruddin D; Marzuki S; Kita K
    Parasitol Int; 2015 Jun; 64(3):295-300. PubMed ID: 25264100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing binding determinants in center P of the cytochrome bc(1) complex using novel hydroxy-naphthoquinones.
    Hughes LM; Covian R; Gribble GW; Trumpower BL
    Biochim Biophys Acta; 2010 Jan; 1797(1):38-43. PubMed ID: 19660431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel hydroxynaphthoquinone 566C80 inhibits the development of liver stages of Plasmodium berghei cultured in vitro.
    Davies CS; Pudney M; Nicholas JC; Sinden RE
    Parasitology; 1993 Jan; 106 ( Pt 1)():1-6. PubMed ID: 8479795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of malaria in Cameroon. XVII. Baseline monitoring of atovaquone-resistant Plasmodium falciparum by in vitro drug assays and cytochrome b gene sequence analysis.
    Basco LK
    Am J Trop Med Hyg; 2003 Aug; 69(2):179-83. PubMed ID: 14506774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro response of Plasmodium falciparum to atovaquone and correlation with other antimalarials: comparison between African and Asian strains.
    Gay F; Bustos D; Traore B; Jardinel C; Southammavong M; Ciceron L; Danis MM
    Am J Trop Med Hyg; 1997 Mar; 56(3):315-7. PubMed ID: 9129535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDQ, a potent inhibitor of Plasmodium falciparum proliferation, binds to the quinone reduction site of the cytochrome bc1 complex.
    Vallières C; Fisher N; Antoine T; Al-Helal M; Stocks P; Berry NG; Lawrenson AS; Ward SA; O'Neill PM; Biagini GA; Meunier B
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3739-47. PubMed ID: 22547613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acridinediones: selective and potent inhibitors of the malaria parasite mitochondrial bc1 complex.
    Biagini GA; Fisher N; Berry N; Stocks PA; Meunier B; Williams DP; Bonar-Law R; Bray PG; Owen A; O'Neill PM; Ward SA
    Mol Pharmacol; 2008 May; 73(5):1347-55. PubMed ID: 18319379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of complex III with bound antimalarial agent CK-2-68 provides insights into selective inhibition of Plasmodium cytochrome bc
    Esser L; Zhou F; Zeher A; Wu W; Huang R; Yu CA; Lane KD; Wellems TE; Xia D
    J Biol Chem; 2023 Jul; 299(7):104860. PubMed ID: 37236355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of atovaquone against the African isolates and clones of Plasmodium falciparum.
    Basco LK; Ramiliarisoa O; Le Bras J
    Am J Trop Med Hyg; 1995 Oct; 53(4):388-91. PubMed ID: 7485692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the mitochondrial electron transport chain of Plasmodium falciparum: new strategies towards the development of improved antimalarials for the elimination era.
    Nixon GL; Pidathala C; Shone AE; Antoine T; Fisher N; O'Neill PM; Ward SA; Biagini GA
    Future Med Chem; 2013 Sep; 5(13):1573-91. PubMed ID: 24024949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.